Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Coll Cardiol ; 37(1): 243-50, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11153746

ABSTRACT

OBJECTIVE: The study objectives were to determine posttransplant coronary artery disease (TxCAD) incidence, predisposing factors and optimal timing for retransplantation (re-Tx) in pediatric heart transplantation (Tx) recipients. BACKGROUND: The TxCAD limits long-term survival following heart Tx, with re-Tx being the primary therapy. Information on risk factors and timing of listing for re-Tx is limited in children. METHODS: The records of children who survived >1 year post-Tx at Loma Linda University were reviewed. Nonimmune and immune risk factors were analyzed. RESULTS: TxCAD was documented in 24 of 210 children. Freedom from TxCAD was 92 +/- 2% and 75 +/- 5% at 5 and 10 years' post-Tx, respectively. The TxCAD diagnosis was established at autopsy in 10 asymptomatic patients who died suddenly within nine months following the most recent negative angiograms. The remaining 14 children had angiographic diagnoses of TxCAD and had symptoms and/or graft dysfunction (n = 10) or positive stress studies (n = 4). Three of 14 died within three months after the diagnosis was made. Eleven patients underwent re-Tx within seven months of diagnosis; nine survived. Univariate and multivariate analyses showed that only late rejection (>1 year posttransplant) frequency (p = 0.025) and severity (hemodynamically compromising) (p < 0.01) were independent predictors of TxCAD development. Freedom from TxCAD after severe late rejection was 78 +/- 8% one year postevent and 55 +/- 10% by two years. CONCLUSIONS: Late rejection is an independent predictor of TxCAD. Patients suffering severe late rejection develop angiographically apparent TxCAD rapidly and must be monitored aggressively. Both TxCAD mortality and morbidity occur early; therefore, we recommend immediate listing for re-Tx upon diagnosis.


Subject(s)
Coronary Disease/diagnosis , Graft Rejection/diagnosis , Heart Transplantation , Adolescent , Child , Child, Preschool , Coronary Disease/mortality , Coronary Disease/surgery , Female , Follow-Up Studies , Graft Rejection/mortality , Graft Rejection/surgery , Humans , Infant , Infant, Newborn , Male , Reoperation , Risk Factors , Survival Analysis
2.
J Am Coll Cardiol ; 32(2): 509-14, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9708484

ABSTRACT

OBJECTIVES: This study was undertaken to investigate the incidence of posttransplant recoarctation of the aorta, delineate the mode of presentation, identify risk factors that predict recoarctation and examine the results of intervention for posttransplant recoarctation. BACKGROUND: Patients with aortic arch hypoplasia require extended arch reconstruction at transplant, with an inherent possibility of subsequent recoarctation of the aorta. METHODS: This was a retrospective review of all children (age <18 years) who underwent cardiac transplantation over a 10-year period. Collected data included pretransplant diagnosis, details of the transplant procedure and posttransplant data including development of recoarctation of the aorta, interventions for recoarctation and the most recent follow-up assessment of the aortic arch. RESULTS: Two hundred eighty-eight transplants were performed on 279 children (follow-up = 1,075 patient-years; range 0 to 133 months, median 43.7). Thirty-two of 152 patients (21%) who underwent extended aortic arch reconstruction subsequently developed recoarctation. All but one patient developed recoarctation within 2 years after transplant; 87% were hypertensive at presentation. Of 30 patients who underwent intervention for recoarctation (balloon angioplasty [n = 26] and surgical repair of recoarctation [n = 4]), 26 (87%) have remained recurrence-free (follow-up = 133 patient-years; range 8 to 106 months, median 47). CONCLUSIONS: The high frequency of recoarctation after cardiac transplantation with extended aortic arch reconstruction mandates serial echocardiographic evaluation of the aortic arch. Patients typically present with systemic hypertension within the first two years after transplantation. Balloon angioplasty is a safe, effective and durable method of treatment.


Subject(s)
Aortic Coarctation/etiology , Heart Transplantation , Adolescent , Angioplasty, Balloon , Aorta, Thoracic/abnormalities , Aorta, Thoracic/surgery , Aortic Coarctation/diagnosis , Aortic Coarctation/diagnostic imaging , Aortic Coarctation/surgery , Aortic Coarctation/therapy , Child , Child, Preschool , Disease-Free Survival , Echocardiography , Female , Follow-Up Studies , Forecasting , Heart Transplantation/adverse effects , Heart Transplantation/diagnostic imaging , Humans , Hypertension/diagnosis , Hypertension/etiology , Incidence , Linear Models , Male , Postoperative Complications , Recurrence , Retrospective Studies , Risk Factors , Safety , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...